PG
AXDX

Patten Group’s Accelerate Diagnostics AXDX Stock Holding History

Patten Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-66
Closed -$8K – 218
2018
Q4 		$8K Sell
66
-66
-50% -$9.78K ﹤0.01% 451
2018
Q3 		$30K Sell
132
-122
-48% -$27K 0.01% 381
2018
Q2 		$57K Sell
254
-23
-8% -$5.14K 0.02% 305
2018
Q1 		$63K Sell
277
-20
-7% -$5.25K 0.03% 295
2017
Q4 		$78K Buy
+297
New +$69.6K 0.03% 283

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Patten Group's AXDX Position: Q1 2019 in Review

Patten Group sold out of Accelerate Diagnostics (AXDX) in Q1 2019, closing a stake of 66 shares — an estimated $8K sold.

Patten Group first reported a position in AXDX in Q4 2017 and held it in 5 quarters. The position peaked at $78K in Q4 2017. 114 funds tracked by Wall St. Rank hold AXDX as of Q1 2019.

  • Patten Group reported no remaining Accelerate Diagnostics position as of Q1 2019 after selling out during the quarter.
  • Patten Group sold 66 Accelerate Diagnostics shares in Q1 2019, an estimated $8K.
  • Patten Group first reported a position in Accelerate Diagnostics in Q4 2017 and held it in 5 quarters.
  • Patten Group's Accelerate Diagnostics position peaked at $78K in Q4 2017.
  • 114 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2019.

Based on Patten Group's 13F filing for Q1 2019, filed 14 May 2019.